Mail

UK markets closed

FTSE 100
8,146.86
-16.81(-0.21%)
FTSE 250
20,120.36
-75.59(-0.37%)
AIM
776.04
-4.39(-0.56%)
GBP/EUR
1.1845
-0.0034(-0.29%)
GBP/USD
1.2686
-0.0075(-0.59%)
Bitcoin GBP
52,132.24
+366.93(+0.71%)

How I founded Britain's most respected removals firm

'Doing removals defines you for the rest of your working life'

Immuneering Corporation (IMRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

1.5100

-0.1800

(-10.65%)

At close: 04:00PM EDT

1.5298

+0.02

(+1.31%)

After hours:

07:45PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	44.78M
Enterprise value	-22.12M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	563.62
Price/book (mrq)	0.57
Enterprise value/revenue	191.91k
Enterprise value/EBITDA	-1.53

Trading information

Stock price history

Beta (5Y monthly)	-0.60
52-week change ³	-86.78%
S&P500 52-week change ³	23.76%
52-week high ³	11.9200
52-week low ³	1.3000
50-day moving average ³	1.6141
200-day moving average ³	5.1489

Share statistics

Avg vol (3-month) ³	660.3k
Avg vol (10-day) ³	269.57k
Shares outstanding ⁵	29.65M
Implied shares outstanding ⁶	29.65M
Float ⁸	17.41M
% held by insiders ¹	29.15%
% held by institutions ¹	34.88%
Shares short (15 May 2024) ⁴	3.53M
Short ratio (15 May 2024) ⁴	9.2
Short % of float (15 May 2024) ⁴	15.98%
Short % of shares outstanding (15 May 2024) ⁴	11.89%
Shares short (prior month 15 Apr 2024) ⁴	2.73M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-37.73%
Return on equity (ttm)	-61.38%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-58.69M
Net income avi to common (ttm)	-54.18M
Diluted EPS (ttm)	-1.8600
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	71.28M
Total cash per share (mrq)	2.4
Total debt (mrq)	4.38M
Total debt/equity (mrq)	5.56%
Current ratio (mrq)	14.38
Book value per share (mrq)	2.65

Cash flow statement

Operating cash flow (ttm)	-50.04M
Levered free cash flow (ttm)	-31.72M